» Articles » PMID: 35565525

Mining the Proteome of Parasites Seeking Vaccine and Diagnostic Candidates

Abstract

is a pathogenic protozoan parasite that infects the nucleated cells of warm-blooded hosts leading to an infectious zoonotic disease known as toxoplasmosis. The infection outcomes might be severe and fatal in patients with immunodeficiency, diabetes, and pregnant women and infants. The One Health approach to toxoplasmosis highlights that the health of humans is closely related to the health of animals and our common environment. The presence of drug resistance and side effects, the further improvement of sensitivity and specificity of serodiagnostic tools and the potentiality of vaccine candidates to induce the host immune response are considered as justifiable reasons for the identification of novel targets for the better management of toxoplasmosis. Thus, the identification of new critical proteins in the proteome of parasites can also be helpful in designing and test more effective drugs, vaccines, and diagnostic tools. Accordingly, in this study we present important proteins found in the proteome of the life cycle-specific stages of parasites that are potential diagnostic or vaccine candidates. The current study might help to understand the complexity of these parasites and provide a possible source of strategies and biomolecules that can be further evaluated in the pathobiology of parasites and for diagnostics and vaccine trials against this disease.

Citing Articles

Proteomics Applications in : Unveiling the Host-Parasite Interactions and Therapeutic Target Discovery.

Deng B, Vanagas L, Alonso A, Angel S Pathogens. 2024; 13(1).

PMID: 38251340 PMC: 10821451. DOI: 10.3390/pathogens13010033.

References
1.
Javadi Mamaghani A, Fathollahi A, Spotin A, Ranjbar M, Barati M, Aghamolaie S . Candidate antigenic epitopes for vaccination and diagnosis strategies of Toxoplasma gondii infection: A review. Microb Pathog. 2019; 137:103788. DOI: 10.1016/j.micpath.2019.103788. View

2.
Huynh M, Boulanger M, Carruthers V . A conserved apicomplexan microneme protein contributes to Toxoplasma gondii invasion and virulence. Infect Immun. 2014; 82(10):4358-68. PMC: 4187870. DOI: 10.1128/IAI.01877-14. View

3.
Foroutan M, Zaki L, Tavakoli S, Soltani S, Taghipour A, Ghaffarifar F . Rhomboid antigens are promising targets in the vaccine development against . EXCLI J. 2019; 18:259-272. PMC: 6635731. DOI: 10.17179/excli2018-1993. View

4.
Tan F, Hu X, Pan C, Ding J, Chen X . Monoclonal antibodies against nucleoside triphosphate hydrolase-II can reduce the replication of Toxoplasma gondii. Parasitol Int. 2010; 59(2):141-6. DOI: 10.1016/j.parint.2009.12.007. View

5.
Zhang Z, Li Y, Xie Q, Li P, Nan X, Kong L . The Molecular Characterization and Immunity Identification of Rhoptry Protein 22 of Toxoplasma gondii as a DNA Vaccine Candidate Against Toxoplasmosis. J Eukaryot Microbiol. 2018; 66(1):147-157. DOI: 10.1111/jeu.12639. View